Enrollment is behind, so the plan is to add clinical research sites. It feels like progress. It looks like a fix. It’s also the most expensive way to ...
Continue readingAccelerating clinical studies is a mission that affects us all.
Enrollment is behind, so the plan is to add clinical research sites. It feels like progress. It looks like a fix. It’s also the most expensive way to ...
Continue readingYou selected your sites carefully. Six months in, enrollment is behind. The instinct: find better sites, bring more online. But site selection wasn’t ...
Continue readingMarket Feasibility helps test patient reach, understanding, and qualification signals earlier. Your patients don’t see a protocol. They see a ...
Continue readingClinical trials are moving toward faster data, faster signals, and faster decisions. The FDA recently announced real-time clinical trial ...
Continue readingAre you still recruiting for “hypertension”… or for the full cardiometabolic reality your protocol actually requires? Hypertension used to be treated ...
Continue readingClinical trial referrals don’t usually fail because patients aren’t interested. They fail because too many patients are pushed downstream before ...
Continue readingObesity remains one of the most commercially important areas in clinical development, but it is also one of the easiest places to misread recruitment ...
Continue reading